<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet Res</journal-id><journal-id journal-id-type="pmc-domain-id">892</journal-id><journal-id journal-id-type="pmc-domain">vetres</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8889640</article-id><article-id pub-id-type="pmcid-ver">PMC8889640.1</article-id><article-id pub-id-type="pmcaid">8889640</article-id><article-id pub-id-type="pmcaiid">8889640</article-id><article-id pub-id-type="pmid">35236406</article-id><article-id pub-id-type="doi">10.1186/s13567-022-01034-z</article-id><article-id pub-id-type="publisher-id">1034</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A <italic toggle="yes">Brucella melitensis</italic> H38&#916;<italic toggle="yes">wbkF</italic> rough mutant protects against <italic toggle="yes">Brucella ovis</italic> in rams</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7970-4929</contrib-id><name name-style="western"><surname>Mu&#241;oz</surname><given-names initials="PM">Pilar M.</given-names></name><address><email>pmmunnoz@cita-aragon.es</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names initials="R">Raquel</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Andr&#233;s-Barranco</surname><given-names initials="S">Sara</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>de Miguel</surname><given-names initials="MJ">Mar&#237;a-Jes&#250;s</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names initials="A">Amaia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names initials="B">Beatriz</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salvador-Besc&#243;s</surname><given-names initials="M">Miriam</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mart&#237;nez-G&#243;mez</surname><given-names initials="E">Estrella</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iriarte</surname><given-names initials="M">Maite</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barber&#225;n</surname><given-names initials="M">Montserrat</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vizca&#237;no</surname><given-names initials="N">Nieves</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names initials="I">Ignacio</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blasco</surname><given-names initials="JM">Jos&#233; M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.420202.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 248X</institution-id><institution>Departamento de Ciencia Animal, </institution><institution>Centro de Investigaci&#243;n y Tecnolog&#237;a Agroalimentaria de Arag&#243;n (CITA), </institution></institution-wrap>Zaragoza, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.11205.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2152 8769</institution-id><institution>Instituto Agroalimentario de Arag&#243;n-IA2 (CITA-Universidad de Zaragoza), </institution></institution-wrap>Zaragoza, Spain </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.5924.a</institution-id><institution-id institution-id-type="ISNI">0000000419370271</institution-id><institution>Instituto de Salud Tropical, Instituto de Investigaci&#243;n Sanitaria de Navarra and Departamento de Microbiolog&#237;a y Parasitolog&#237;a, </institution><institution>Universidad de Navarra, </institution></institution-wrap>Pamplona, Spain </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.4489.1</institution-id><institution-id institution-id-type="ISNI">0000000121678994</institution-id><institution>Otology and Neurotology Group CTS495, Department of Genomic Medicine, </institution><institution>GENYO Centre for Genomics and Oncological Research, Pfizer-University of Granada-Junta de Andaluc&#237;a, </institution></institution-wrap>Granada, Spain </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.11205.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2152 8769</institution-id><institution>Departamento de Patolog&#237;a Animal, </institution><institution>Universidad de Zaragoza, </institution></institution-wrap>Zaragoza, Spain </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.11762.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 1817</institution-id><institution>Departamento de Microbiolog&#237;a y Gen&#233;tica, </institution><institution>Universidad de Salamanca, </institution></institution-wrap>Salamanca, Spain </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>3</month><year>2022</year></pub-date><pub-date pub-type="ppub"><year>2022</year></pub-date><volume>53</volume><issue-id pub-id-type="pmc-issue-id">397981</issue-id><elocation-id>16</elocation-id><history><date date-type="received"><day>9</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>03</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>09</day><month>03</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-03-10 00:16:48.480"><day>10</day><month>03</month><year>2022</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2022</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13567_2022_Article_1034.pdf"/><abstract id="Abs1"><p id="Par1"><italic toggle="yes">Brucella melitensis</italic> and <italic toggle="yes">Brucella ovis</italic> are gram-negative pathogens of sheep that cause severe economic losses and, although <italic toggle="yes">B. ovis</italic> is non-zoonotic, <italic toggle="yes">B. melitensis</italic> is the main cause of human brucellosis. <italic toggle="yes">B. melitensis</italic> carries a smooth (S) lipopolysaccharide (LPS) with an N-formyl-perosamine O-polysaccharide (O-PS) that is absent in the rough LPS of <italic toggle="yes">B. ovis</italic>. Their control and eradication require vaccination, but <italic toggle="yes">B. melitensis</italic> Rev 1, the only vaccine available, triggers anti-O-PS antibodies that interfere in the S-brucellae serodiagnosis. Since eradication and serological surveillance of the zoonotic species are priorities, Rev 1 is banned once <italic toggle="yes">B. melitensis</italic> is eradicated or where it never existed, hampering <italic toggle="yes">B. ovis</italic> control and eradication. To develop a <italic toggle="yes">B. ovis</italic> specific vaccine, we investigated three <italic toggle="yes">Brucella</italic> live vaccine candidates lacking N-formyl-perosamine O-PS: Bov::CA&#916;<italic toggle="yes">wadB</italic> (CO<sub>2</sub>-independent <italic toggle="yes">B. ovis</italic> with truncated LPS core oligosaccharide); Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (carrying N-acetylated O-PS); and H38&#916;<italic toggle="yes">wbkF</italic> (<italic toggle="yes">B. melitensis</italic> rough mutant with intact LPS core). After confirming their attenuation and protection against <italic toggle="yes">B. ovis</italic> in mice, were tested in rams for efficacy. H38&#916;<italic toggle="yes">wbkF</italic> yielded similar protection to Rev 1 against <italic toggle="yes">B. ovis</italic> but Bov::CA&#916;<italic toggle="yes">wadB</italic> and Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> conferred no or poor protection, respectively. All H38&#916;<italic toggle="yes">wbkF</italic> vaccinated rams developed a protracted antibody response in ELISA and immunoprecipitation <italic toggle="yes">B. ovis</italic> diagnostic tests. In contrast, all remained negative in Rose Bengal and complement fixation tests used routinely for <italic toggle="yes">B. melitensis</italic> diagnosis, though some became positive in S-LPS ELISA owing to LPS core epitope reactivity. Thus, H38&#916;<italic toggle="yes">wbkF</italic> is an interesting candidate for the immunoprophylaxis of <italic toggle="yes">B. ovis</italic> in <italic toggle="yes">B. melitensis</italic>-free areas.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13567-022-01034-z.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Sheep</kwd><kwd>brucellosis</kwd><kwd><italic toggle="yes">Brucella</italic></kwd><kwd><italic toggle="yes">B. ovis</italic></kwd><kwd>rough</kwd><kwd>vaccine</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100011033</institution-id><institution>Agencia Estatal de Investigaci&#243;n</institution></institution-wrap></funding-source><award-id>AGL2014-58795-C4-1/3/4-R</award-id><award-id>PID2019-107601RB-C31</award-id><award-id>BES-2015-075609</award-id><principal-award-recipient><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names>Beatriz</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010067</institution-id><institution>Gobierno de Arag&#243;n</institution></institution-wrap></funding-source><award-id>A13_17R</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>ISTUN</institution></funding-source><award-id>LCF/PR/PR13/11080005</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Brucellosis is a worldwide extended disease caused by gram-negative bacteria of the genus <italic toggle="yes">Brucella</italic> that has a severe impact on animal and human health [<xref ref-type="bibr" rid="CR1">1</xref>]. The genus includes several species among which <italic toggle="yes">B. melitensis</italic> primarily produces brucellosis in sheep and goats and is the major cause of human brucellosis [<xref ref-type="bibr" rid="CR2">2</xref>]. <italic toggle="yes">B. melitensis</italic> cells have a surface smooth (S)-type lipopolysaccharide (LPS) made of a lipid A-core oligosaccharide linked to an N-formylperosamine O-polysaccharide (O-PS) that carries the epitopes relevant in S <italic toggle="yes">Brucella</italic> serodiagnostic tests [<xref ref-type="bibr" rid="CR3">3</xref>]. Sheep can also be infected by <italic toggle="yes">B. ovis</italic>, a species that displays a rough (R) LPS because it lacks a complete set of functional O-PS genes [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Although non-zoonotic, <italic toggle="yes">B. ovis</italic> causes a serious disease manifested by genital lesions in rams and placentitis and abortions in ewes that result in important economic losses [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par3">While some countries have eradicated <italic toggle="yes">B. melitensis</italic> through the combined use of vaccination and test and slaughter programs [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], none has eradicated <italic toggle="yes">B. ovis</italic>. Attempts to eradicate <italic toggle="yes">B. ovis</italic> infection, sometimes misnamed ovine epididymitis, have often been focused exclusively on ram testing and culling, a strategy that has failed consistently because it overlooks the important epidemiological role of ewes [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. Moreover, testing and culling becomes economically unfeasible when prevalence is moderate or high, making vaccination against <italic toggle="yes">B. ovis</italic> indispensable [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Nevertheless, the only vaccine available for the immunoprophylaxis of <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> is <italic toggle="yes">B. melitensis</italic> Rev 1, a live-attenuated S strain that elicits antibodies to the O-PS that interfere in <italic toggle="yes">B. melitensis</italic> serodiagnostic tests. Since these vaccinal antibodies encumber <italic toggle="yes">B. melitensis</italic> eradication and surveillance and this zoonotic species is a priority, Rev 1 is banned after <italic toggle="yes">B. melitensis</italic> eradication, and the same reasons make Rev 1 unsuitable for use in <italic toggle="yes">B. melitensis</italic>-free countries but yet affected by <italic toggle="yes">B. ovis</italic>. Hence, the development of <italic toggle="yes">B. ovis</italic>-specific vaccines is of great interest, as proven by the dramatic increase in <italic toggle="yes">B. ovis</italic> prevalence in European Union countries shortly after Rev 1 withdrawal [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par4">Altering the antigenic structure of S <italic toggle="yes">Brucella</italic> has been the preferred strategy to develop vaccines that circumvent the interference in S serological tests. Logically, O-PS removal was the first choice and some R mutants have been investigated as <italic toggle="yes">B. ovis</italic> vaccines. The empirically developed <italic toggle="yes">B. abortus</italic> RB51 (the only R vaccine currently marketed) does not confer adequate protection against either <italic toggle="yes">B. melitensis</italic> or <italic toggle="yes">B. ovis</italic> [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. However, experiments in mice show that genetically well-defined R vaccines are superior to RB51 and could be effectual against <italic toggle="yes">B. ovis</italic> [<xref ref-type="bibr" rid="CR16">16</xref>]. An antigen removal strategy was also followed to obtain a <italic toggle="yes">B. melitensis</italic> Rev 1 lacking protein BP26 but, although effective against <italic toggle="yes">B. ovis</italic>, this Rev 1 derivative obviously triggers anti-O-PS antibodies and the associated BP26-iELISA is not sensitive enough to be used as differential test [<xref ref-type="bibr" rid="CR17">17</xref>]. Following a positive tagging strategy, a Rev 1 vaccine carrying the green fluorescent protein (GFP) gene and its ancillary GFP-ELISA were investigated in sheep [<xref ref-type="bibr" rid="CR18">18</xref>]. Yet, co-inoculation of the GFP-tagged vaccine with soluble GFP plus a GFP booster in Freund&#8217;s adjuvant ten weeks later are necessary to trigger GFP antibodies matching the persistence of O-PS antibodies, a protocol of no practical use. Finally, Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>, a construct carrying <italic toggle="yes">wbdR</italic> (an <italic toggle="yes">E. coli</italic> LPS acetyl-transferase gene) instead of <italic toggle="yes">wbk</italic>C (the <italic toggle="yes">Brucella</italic> LPS formyl-transferase gene) conferred protection against <italic toggle="yes">B. ovis</italic> in mice and displayed a N-acetyl-perosamine O-PS structure triggering antibodies that could be differentiated from those induced by <italic toggle="yes">B. melitensis</italic> in this laboratory model [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par5">Since it is a naturally R species, a homologous <italic toggle="yes">B. ovis</italic> vaccine could also be an alternative to Rev 1. Classical bacterins in adjuvant are unsatisfactory as <italic toggle="yes">B. ovis</italic> vaccines [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>] and, although adjuvant-encapsulated outer membrane-rich extracts are effective [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], the complexity of their preparation and the need for revaccinations make these vaccines expensive and unpractical. Recently, a polymeric BLSOmp31 antigen in oil adjuvant has been proposed as a <italic toggle="yes">B. ovis</italic> vaccine but the vaccine did not prevent infection in rams [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. An alginate-encapsulated <italic toggle="yes">B. ovis</italic> mutant in a putative ABC transporter has been reported to confer perfect protection in rams [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] but this claim was based on a deficient bacteriological search for the challenge strain as only minimal aliquots of diluted homogenates were cultured and some important target organs [<xref ref-type="bibr" rid="CR26">26</xref>] were not examined. In mice, we have reported that Omp25d and Omp22 mutants, a triple Omp10-Omp31-SP41 mutant and mutants with a truncated LPS-core lateral branch are attenuated and protect against <italic toggle="yes">B</italic>. <italic toggle="yes">ovis</italic> [<xref ref-type="bibr" rid="CR27">27</xref>&#8211;<xref ref-type="bibr" rid="CR29">29</xref>]. In parallel, we have investigated <italic toggle="yes">B. ovis</italic> CO<sub>2</sub>-dependence, a characteristic of this species that would encumber a practical use of homologous vaccines. This trait relates to mutations in carbonic anhydrase (CA) genes and can be abrogated by insertion of CA homologues of CO<sub>2</sub>-independent brucellae without affecting virulence in mice [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par6">In this work, we pursued three of the above-summarized strategies to develop <italic toggle="yes">B. ovis</italic> vaccines minimizing the interference in O-PS serological tests. For the R vaccine approach, we investigated a <italic toggle="yes">B. melitensis</italic> H38 <italic toggle="yes">wbkF</italic> mutant carrying an R-LPS with intact core oligosaccharide. This choice was based on previous works that show that dysfunction of this gene in this strain, while not matching Rev 1, results in adequate attenuation and better protection against <italic toggle="yes">B. melitensis</italic> in sheep than that obtained with mutants in other LPS genes [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. In the Rev 1 background, we studied the above-described Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>. Finally, we also examined a <italic toggle="yes">B. ovis</italic> CO<sub>2-</sub>independent construct deleted in <italic toggle="yes">wadB</italic>, a gene necessary for full assembly of the R-LPS core oligosaccharide lateral branch of brucellae.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Bacterial strains, conservation and growth conditions</title><p id="Par7">The parental strains used for the construction of the vaccine candidate mutants are described below. Bov::CA is a <italic toggle="yes">B. ovis</italic> PA derivative carrying the active carbonic anhydrase (CAI and CAII) genes of <italic toggle="yes">B. abortus</italic> 2308&#160;W in a stable Tn7 insert in chromosome II that is CO<sub>2</sub>-independent and retains the virulence of the wild-type in the mouse model [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. <italic toggle="yes">B. melitensis</italic> H38 is a S virulent strain used previously in the analysis of LPS genes [<xref ref-type="bibr" rid="CR32">32</xref>], and <italic toggle="yes">B. melitensis</italic> Rev 1 is the OIE recommended sheep brucellosis vaccine [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par8"><italic toggle="yes">B. ovis</italic> PA (wild-type, virulent, serum and CO<sub>2</sub>-dependent) and its kanamycin-resistant virulent derivative (BoPA-Km<sup>R</sup>) have been respectively used as challenge strains in sheep and mice in previous works [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par9">All the above bacteria and the corresponding mutants (see below) were maintained freeze-dried or in skimmed milk at &#8722;80&#160;&#176;C in the CITA (Zaragoza, Spain) <italic toggle="yes">Brucella</italic> culture collection. To prepare the bacterial suspensions for the experiments described below, the stocks were rehydrated or thawed and seeded onto Blood Agar Base (BAB no. 2, OXOID, USA) or BAB with 5% sterile calf serum (BAB-S, for <italic toggle="yes">B. ovis</italic> PA) plates, for 3&#8211;4&#160;days at 37&#160;&#176;C in air or, for <italic toggle="yes">B. ovi</italic>s PA, in 10% CO<sub>2</sub> atmospheres.</p></sec><sec id="Sec4"><title>Construction and characteristics of vaccine candidates</title><p id="Par10">The origin and characteristics of the primers and plasmids used in this work are presented in Additional files <xref rid="MOESM1" ref-type="media">1</xref> and <xref rid="MOESM2" ref-type="media">2</xref>, respectively.</p><p id="Par11">Bov::CA&#916;<italic toggle="yes">wadB</italic> was constructed using the suicide plasmid pJQK&#916;<italic toggle="yes">wadB</italic> (pYRI-2 in [<xref ref-type="bibr" rid="CR36">36</xref>]), which was introduced into Bov::CA by conjugation with <italic toggle="yes">E. coli</italic> S17 &#955;pir [<xref ref-type="bibr" rid="CR37">37</xref>]. The first recombination event was selected by nalidixic and kanamycin resistance and the double recombination by nalidixic and sucrose resistance, and kanamycin sensitivity. Deletion of <italic toggle="yes">wadB</italic> was confirmed by PCR using oligonucleotides <italic toggle="yes">wadB</italic>-F1 and <italic toggle="yes">wadB</italic>-R4 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>), which amplified a fragment of 570 base pairs (bp) in the mutant and a fragment of 1011&#160;bp in the sibling revertant strain. Oligonucleotides <italic toggle="yes">wadB-</italic>F1 and <italic toggle="yes">wadB</italic>-R5 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>), which amplify a fragment of 471&#160;bp only in the wild-type strain, were used to verify the deletion.</p><p id="Par12"><italic toggle="yes">Brucella melitensis</italic> H38&#916;<italic toggle="yes">wbkF</italic> (R mutant in-frame deleted in the bactoprenol priming for O-PS polymerization gene; henceforth H38&#916;<italic toggle="yes">wbkF</italic>) was constructed using the same methodology and genetic tools described for the homologous <italic toggle="yes">B. suis</italic> Bs2&#916;<italic toggle="yes">wbkF</italic> mutant [<xref ref-type="bibr" rid="CR38">38</xref>]. Briefly, pJQK&#916;<italic toggle="yes">wbkF</italic> was transformed into competent <italic toggle="yes">E. coli</italic> S17 &#955;pir (Additional file <xref rid="MOESM2" ref-type="media">2</xref>) and, after conjugation with <italic toggle="yes">B. melitensis</italic> H38, the first recombination event was selected by nalidixic acid and kanamycin resistance, and the double recombination by nalidixic and sucrose resistance, and kanamycin sensitivity. Deletion of <italic toggle="yes">wbkF</italic> was confirmed by PCR using oligonucleotides <italic toggle="yes">wbkF</italic>-F1 and <italic toggle="yes">wbkF</italic>-R4 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>), which amplified a fragment of 953&#160;bp in the mutant and a fragment of 1796&#160;bp in the sibling revertant strain. Oligonucleotides <italic toggle="yes">wbkF</italic>-F1 and <italic toggle="yes">wbkF</italic>-R6 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>), which amplified a fragment of 680&#160;bp only in the wild-type strain, were used to verify the deletion.</p><p id="Par13">Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construction and characterization has been described in a previous work [<xref ref-type="bibr" rid="CR19">19</xref>]. Briefly, Rev1::<italic toggle="yes">wbdR</italic> was obtained inserting <italic toggle="yes">wbdR</italic> in chromosome II of <italic toggle="yes">B. melitensis</italic> Rev 1 using a Tn7 strategy [<xref ref-type="bibr" rid="CR39">39</xref>]. Then, <italic toggle="yes">wbkC</italic> (formyltransferase gene) was deleted to obtain Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC,</italic> which carries <italic toggle="yes">N</italic>-acetyl-perosamine instead of <italic toggle="yes">N</italic>-formyl-perosamine as proved by immunochemical and NMR analyses [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par14">All vaccine candidates were stored at &#8722;80&#160;&#176;C in skimmed milk and grown as described above.</p></sec><sec id="Sec5"><title>Virulence and protection studies in mice</title><p id="Par15">These experiments were carried out using seven-week-old female BALB/c mice (ENVIGO, Harlan) that were maintained in a BSL-3 facility (ES/31-2010-000132) with water and food ad libitum for 2&#160;weeks before and during the experiments in accordance with the current European (directive 86/609/EEC) and Spanish (RD 53/2013) legislations.</p><p id="Par16">To obtain inocula, fresh cultures (see &#8220;<xref rid="Sec3" ref-type="sec">Bacterial strains, conservation and growth conditions</xref>&#8221;) were harvested in buffered saline solution (BSS; 0.015&#160;M NaCl, 7&#160;mM KH<sub>2</sub>PO<sub>4</sub>, 10&#160;mM K<sub>2</sub>HPO<sub>4</sub>; pH 6.85) and suspensions adjusted spectrophotometrically (600&#160;nm) to the appropriate dose (see below). Purity, absence of S-R dissociation (when appropriate) and exact doses (triplicate measurements) were assessed retrospectively following standard protocols [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par17">The virulence and protection assessment in mice of Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and Rev 1 parental strain have been published previously [<xref ref-type="bibr" rid="CR19">19</xref>]. For virulence assessment of H38&#916;<italic toggle="yes">wbkF</italic> and Bov::CA&#916;<italic toggle="yes">wadB</italic> mutants (this work), groups of 5 mice were inoculated intraperitoneally with the doses established as optimal (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>) in preliminary experiments (not shown). The three vaccine candidates (Bov::CA&#916;<italic toggle="yes">wadB</italic>, Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and H38&#916;<italic toggle="yes">wbkF</italic>) were inoculated at 10<sup>8</sup>&#160;CFU/mouse, a dose considered optimal for immunization with R mutants in previous experiments in mice [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]; BoPA and Bov::CA parental strains were inoculated at 5&#8201;&#215;&#8201;10<sup>6</sup>&#160;CFU/mouse, as established previously [<xref ref-type="bibr" rid="CR31">31</xref>]. Also, the lowest dose of <italic toggle="yes">B. melitensis</italic> H38 (10<sup>4</sup>&#160;CFU/mouse) inducing a suitable spleen colonization was determined in preliminary experiments (not shown). Mice were euthanized at two different time points, selected for each mutant according previous works [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]: the first point corresponds to the expected &#8220;peak of multiplication&#8221; (week 1 and week 3 for <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> strains, respectively) and the second one, to a later stage of infection (week 5 or 8). The residual virulence was determined by plating spleen homogenates on the appropriate agar medium (see above) and calculating the mean log<sub>10</sub> CFU/spleen&#8201;&#177;&#8201;SD [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par18">To evaluate the protective efficacy, groups of 5 mice were vaccinated subcutaneously with 10<sup>8</sup>&#160;CFU of each vaccine candidate [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Controls were similar groups vaccinated with 10<sup>5</sup>&#160;CFU of Rev 1 or inoculated with BSS as a placebo vaccine. All mice were challenged with 5&#8201;&#215;&#8201;10<sup>6</sup>&#160;CFU of BoPA-Km<sup>R</sup> (see above) administered intraperitoneally 4&#160;weeks after vaccination. The mean log<sub>10</sub> CFU/spleen&#8201;&#177;&#8201;SD of the challenge strain in each group was determined 2&#160;weeks later by plating spleen homogenates on BAB-S supplemented with kanamycin (50&#160;&#956;g/mL) and incubation for 3&#8211;5&#160;days in 10% CO<sub>2</sub>. Results were compared statistically (one-way ANOVA and Fisher&#8217;s Protected Least Significant Differences &#8211;PLSD- post-hoc tests) with those of unvaccinated (BSS) and Rev 1 vaccinated controls.</p></sec><sec id="Sec6"><title>Ram vaccination and challenge</title><p id="Par19">The experiment in rams was performed in compliance with the current European (86/609/EEC) and Spanish (RD 53/2013) legislations on the use and protection of experimental animals.</p><p id="Par20">Sixty-nine 4-month-old brucellosis-free Rasa Aragonesa rams of similar weight and body condition were randomly allotted and maintained in five separate pens throughout the experiment. To prepare the inocula, suspensions of bacteria (grown and harvested in BSS as described above) were adjusted spectrophotometrically (600&#160;nm) to the appropriate concentration (10<sup>9</sup>&#160;CFU/mL for Rev 1, 10<sup>10</sup>&#160;CFU/mL for the mutant candidates and 10<sup>11</sup>&#160;CFU/mL for <italic toggle="yes">B. ovis</italic> PA challenge strain). Purity, absence of S-R dissociation (when appropriate) and exact doses (triplicate measurements) were assessed retrospectively [<xref ref-type="bibr" rid="CR40">40</xref>]. In the same day, three groups of 14 rams each were immunized subcutaneously in the left elbow with 4&#160;mL of each vaccine candidate. As controls, a fourth group (<italic toggle="yes">n</italic>&#8201;=&#8201;14) was vaccinated with 2&#160;mL of Rev 1 and a fifth group (<italic toggle="yes">n</italic>&#8201;=&#8201;13) was kept unvaccinated. Retrospective assessment showed that each ram received 9.6&#8201;&#215;&#8201;10<sup>9</sup>&#160;CFU of Bov::CA&#916;<italic toggle="yes">wadB</italic>, 2.5&#8201;&#215;&#8201;10<sup>10</sup>&#160;CFU of Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>, 2.5&#8201;&#215;&#8201;10<sup>10</sup>&#160;CFU of H38&#916;<italic toggle="yes">wbkF</italic> and 1.6&#8201;&#215;&#8201;10<sup>9</sup>&#160;CFU of Rev 1. In the next two weeks, all rams were inspected for rectal temperature and local reactions at the inoculation site every two days.</p><p id="Par21">Eight months after vaccination (when Rev 1 and the vaccine candidates had been cleared [<xref ref-type="bibr" rid="CR33">33</xref>]), rams were challenged with 2.5&#8201;&#215;&#8201;10<sup>9</sup>&#160;CFU in 100 &#181;L (determined by retrospective assessment) of <italic toggle="yes">B. ovis</italic> PA given by both conjunctival (50 &#181;L) and preputial (50 &#181;L) routes, and then clinically examined at weekly intervals. Eight weeks after challenge, they were euthanatized for bacteriological examination. For this, large portions of spleen and epididymides, the whole vesicular glands and ampullae, and the whole cranial (submaxillary, parotid and retropharyngeal), iliac, scrotal, prefemoral and superficial cervical lymph nodes were collected and submitted to culture on a suitable selective medium (see below). Briefly, each organ sample was degreased, superficially sterilized by gentle burning and homogenized in minimal amount of BSS (1&#160;mL per 10&#160;g of tissue, approx.) using a stomacher. Each tissue homogenate was cultured by plating 1&#160;mL in each of duplicate plates of CITA medium [<xref ref-type="bibr" rid="CR42">42</xref>]. Cultures were examined under a stereomicroscope after 5&#8211;7&#160;days of incubation at 37&#160;&#176;C in a 10% CO<sub>2</sub> atmosphere, and suspicious colonies streaked on BAB-S plates for identification by both standard procedures [<xref ref-type="bibr" rid="CR40">40</xref>] and Bruce-ladder multiplex PCR [<xref ref-type="bibr" rid="CR43">43</xref>]. A ram was classified as infected if at least one <italic toggle="yes">B. ovis</italic> PA CFU was isolated from any of the organs or lymph nodes sampled. The infection level of each sample was semi-quantitatively scored as follows: level 1, 1&#8211;5&#160;CFU/plate; level 2, 6&#8211;25&#160;CFU/plate; level 3, 26&#8211;125&#160;CFU/plate; level 4, 126&#8211;250&#160;CFU/plate; and level 5,&#8201;&gt;&#8201;250&#160;CFU/plate (samples with level equal or higher than 3 were considered as severely infected, and rams showing at least one severely infected organ were counted as severely infected animals). Statistical comparisons of numbers of <italic toggle="yes">B. ovis</italic> infected (and severely infected) animals were made by Chi-square test (Fisher-Yates correction was applied when required). Numbers of infected (and severely infected) organs per animal were compared by STEPBOOT MULTTEST (5.0, SAS Institute Inc. Copyright&#169;).</p><p id="Par22">For serological studies, blood samples were taken before vaccination, one week after vaccination and every two or three weeks (including one week after challenge) until the end of the experiment.</p></sec><sec id="Sec7"><title>Serological tests</title><p id="Par23">The Rose Bengal (RBT) and the complement fixation (CFT) tests for S <italic toggle="yes">Brucella</italic> were performed according to standard methods [<xref ref-type="bibr" rid="CR34">34</xref>], and the S-LPS iELISA was performed as described before [<xref ref-type="bibr" rid="CR44">44</xref>] using gold standard sera (from 46 <italic toggle="yes">B. melitensis</italic> culture positive and 78 brucellosis-free sheep) to determine the appropriate cut-off. The agar gel immunodiffusion (AGID) test for the serodiagnosis of <italic toggle="yes">B. ovis</italic> [<xref ref-type="bibr" rid="CR45">45</xref>] was performed in 3&#160;mm thick gels of 1% Noble Agar (Difco, USA) in borate buffer (0.1&#160;M, pH 8.3)-10% NaCl using the recommended <italic toggle="yes">B. ovis</italic> REO 198 hot saline (HS) extract (rich in outer membrane proteins and R-LPS [<xref ref-type="bibr" rid="CR46">46</xref>]) as antigen, and presence of precipitation bands was examined after 48&#160;h of incubation at room temperature in a humid chamber. In addition, depending on the vaccine candidate (see &#8220;<xref rid="Sec8" ref-type="sec">Results</xref>&#8221;), the antibody response was also examined by indirect ELISA (iELISA) using the appropriate antigen as described below.</p><p id="Par24">The iELISA with HS extract of either <italic toggle="yes">B. ovis</italic> PA or Bov::CA&#916;<italic toggle="yes">wadB</italic> was performed on standard 96-well polystyrene plates (Costar &#174;, USA). Optimal coating conditions (antigen at 2.5&#160;&#181;g/mL in carbonate buffer [0.06&#160;M, pH 9.6] at 37&#160;&#176;C overnight), serum dilution (1/100) and conjugate (recombinant Protein G-HRPO, Thermo Fisher Scientific, USA at 0.2&#160;&#956;g/mL) were determined by previous titration with gold-standard sera from 46 <italic toggle="yes">B. ovis</italic> culture-positive and 78 brucellosis-free sheep. A 0.1% solution of 2, 2-azinobis, 3-ethyl-benzothiazoline sulfonic acid diammonium salt (ABTS; Sigma Chemical Co., USA) with 0.004% H<sub>2</sub>O<sub>2</sub> in citrate buffer (0.05&#160;M, pH 4) was used as the substrate, and optical density readings (OD<sub>405nm,</sub> Labsystems Multiskan RC) obtained after 15&#160;min of incubation at room temperature. Results were expressed as the percentage of OD<sub>405nm</sub> with respect to a positive control serum. Under these conditions, sera showing % OD<sub>405nm</sub> above 40% (cut-off resulting in 100% specificity and maximum [98%] sensitivity with the gold standard sera) were considered positive.</p><p id="Par25">An iELISA with N-acetyl-perosamine O-PS was performed using a LPS rich extract of the previously described <italic toggle="yes">B. abortus</italic> 2308&#160;W <italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construct [<xref ref-type="bibr" rid="CR19">19</xref>]. This <italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC-</italic>iELISA was optimized using the same panel of gold-standard sera employed in the standard S-LPS ELISA (see above). Costar &#174; plates were coated with 2.5&#160;&#956;g/mL of antigen in carbonate buffer (pH 9.6) at 37&#160;&#176;C overnight. Sera were tested at 1/100 dilution and the Protein-G-HRP (0.2&#160;&#956;g/mL) and the ABTS-H<sub>2</sub>O<sub>2</sub> mixture described above were used as conjugate and substrate, respectively. The OD<sub>405nm</sub> readings and % OD<sub>405nm</sub> were obtained as described above and sera showing %OD<sub>405nm</sub>&#8201;&#8805;&#8201;50% (optimal cut-off) were scored as positive.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Characterization of vaccine candidates</title><p id="Par26">Table <xref rid="Tab1" ref-type="table">1</xref> summarizes the relevant characteristics of the vaccine candidates investigated. Analyses by SDS-PAGE and Western blot with monoclonal antibody A68/24G12/A08 (which discriminates intact and truncated <italic toggle="yes">Brucella</italic> LPS core oligosaccharides [<xref ref-type="bibr" rid="CR36">36</xref>]) and polyclonal sera of the appropriate specificity [<xref ref-type="bibr" rid="CR39">39</xref>], confirmed that the three candidates displayed the phenotype predicted according to previous works with homologous or heterologous <italic toggle="yes">Brucella</italic> mutants and constructs: (i) H38&#916;<italic toggle="yes">wbkF</italic> carried a R-LPS with a complete core; (ii) Bov::CA&#916;<italic toggle="yes">wadB</italic> R-LPS showed the molecular weight shift and epitope defect that correspond to a truncated LPS core lateral branch; and (iii) Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> displayed the shorter O-PS and the epitopic changes associated with the presence of N-acetyl-perosamine and absence of N-formyl-perosamine in the O-PS (Additional file <xref rid="MOESM3" ref-type="media">3</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p><bold>Vaccine candidates</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">Vaccine</italic></th><th align="left" colspan="1" rowspan="1">Genetic characteristics</th><th align="left" colspan="1" rowspan="1">Relevant phenotype</th><th align="left" colspan="1" rowspan="1">References</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic></td><td align="left" colspan="1" rowspan="1">Rev 1 <italic toggle="yes">wbkC</italic> (formyl-transferase gene) deleted mutant carrying a mini-Tn7 insert with <italic toggle="yes">E. coli</italic> O157:H7 <italic toggle="yes">wbdR</italic> (acetyl-transferase)</td><td align="left" colspan="1" rowspan="1">S-LPS with N-acetyl-perosamine O-PS</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR19">19</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">H38&#916;<italic toggle="yes">wbkF</italic></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">B. melitensis</italic> H38 <italic toggle="yes">wbkF</italic> (bactoprenol priming for O-PS polymerization gene) deleted mutant</td><td align="left" colspan="1" rowspan="1">R-LPS with intact core oligosaccharide</td><td align="left" colspan="1" rowspan="1">This work</td></tr><tr><td align="left" colspan="1" rowspan="1">Bov::CA&#916;<italic toggle="yes">wadB</italic></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">B. ovis</italic> PA <italic toggle="yes">wadB</italic> (core sugar glycosyl transferase gene) deleted mutant carrying a mini-Tn7 insert with the carbonic anhydrases (CAI and CAII) genes of <italic toggle="yes">B. abortus</italic> 2308&#160;W</td><td align="left" colspan="1" rowspan="1">CO<sub>2</sub>-independent; R-LPS with a truncated core oligosaccharide</td><td align="left" colspan="1" rowspan="1">This work. &#916;<italic toggle="yes">wadB</italic> and::CA single mutants in [<xref ref-type="bibr" rid="CR27">27</xref>] and [<xref ref-type="bibr" rid="CR30">30</xref>], respectively</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec10"><title>Residual virulence and protection in mice</title><p id="Par27">These studies showed that the three vaccine candidates have attenuated virulence profiles with respect to their virulent counterparts (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Bov::CA&#916;<italic toggle="yes">wadB</italic> (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>A) showed significantly lower CFU/spleen numbers than <italic toggle="yes">B. ovis</italic> PA virulent strains at weeks 3 (expected peak of multiplication for <italic toggle="yes">B. ovis</italic>) and 8 after inoculation. Attenuation with respect to the parental strain was clearly observed also for Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>B, from [<xref ref-type="bibr" rid="CR19">19</xref>]) at post-inoculation weeks 1 (peak of multiplication for <italic toggle="yes">B. melitensis</italic>) and 5. H38&#916;<italic toggle="yes">wbkF</italic> (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>C) yielded similar CFU/spleen numbers to the parental strain at week 1, but the mutant attenuation was evident at later stages (week 5).<fig id="Fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Multiplication profiles in mice of the vaccine candidates Bov::CA&#916;</bold><bold><italic toggle="yes">wadB</italic></bold><bold> (A), Rev1::</bold><bold><italic toggle="yes">wbdR</italic></bold><bold>&#916;</bold><bold><italic toggle="yes">wbkC</italic></bold><bold> (B, taken from </bold>[<xref ref-type="bibr" rid="CR19">19</xref>]<bold>) and H38&#916;</bold><bold><italic toggle="yes">wbkF</italic></bold><bold> (C) with respect to their corresponding parental strains</bold>. Mice were inoculated intraperitoneally with the doses (CFU/mouse) indicated in brackets for each strain. Significant differences: **&#8201;=&#8201;<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***&#8201;=&#8201;<italic toggle="yes">p</italic>&#8201;&lt;&#8201;00.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13567_2022_1034_Fig1_HTML.jpg"/></fig></p><p id="Par28">Using this model, we tested all vaccine candidates for protection against <italic toggle="yes">B. ovis</italic> in two successive experiments. As can be seen in Table <xref rid="Tab2" ref-type="table">2</xref>, the results obtained with all vaccine candidates were not statistically different from those obtained with the Rev 1 vaccine.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p><bold>Protection against </bold><bold><italic toggle="yes">B. ovis</italic></bold><bold> PA-Km</bold><sup><bold>R</bold></sup><bold> in mice</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Experiment</th><th align="left" colspan="1" rowspan="1">Vaccine (CFU dose)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">B. ovis</italic> PA-Km<sup>R</sup> (mean&#8201;&#177;&#8201;SD of log<sub>10</sub> CFU/spleen)</th><th align="left" colspan="1" rowspan="1">Units of protection<sup>a</sup></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Bov::CA&#916;<italic toggle="yes">wadB</italic> (10<sup>8</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.46&#8201;&#177;&#8201;1.68<sup>b,c</sup></td><td align="left" colspan="1" rowspan="1">3.6</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">H38&#916;<italic toggle="yes">wbkF</italic> (10<sup>8</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">3.42&#8201;&#177;&#8201;0.62<sup>b,c</sup></td><td align="left" colspan="1" rowspan="1">2.6</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Rev 1 (10<sup>5</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.50&#8201;&#177;&#8201;1.49<sup>b</sup></td><td align="left" colspan="1" rowspan="1">3.5</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Placebo (BSS)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">6.04&#8201;&#177;&#8201;0.46</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (10<sup>8</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.16&#8201;&#177;&#8201;0.95<sup>b,c</sup></td><td align="left" colspan="1" rowspan="1">4.1</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Rev 1 (10<sup>5</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.45&#8201;&#177;&#8201;1.35<sup>b</sup></td><td align="left" colspan="1" rowspan="1">3.8</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Placebo (BSS)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">6.26&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1">0</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Units of protection: average log<sub>10</sub> CFU of challenge strain in the spleens of placebo (BSS) controls minus average of log<sub>10</sub> CFU of the challenge strain in the spleens of vaccinated mice. <sup>b</sup>Significant differences (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01) versus the placebo (BSS) control group (ANOVA and Fisher&#8217;s PSLD test); <sup>c</sup>No significant differences versus the Rev 1 vaccinated group (ANOVA and Fisher&#8217;s PSLD test).</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Protection in rams</title><p id="Par29">No relevant clinical signs were evidenced after vaccination. The mean rectal temperature remained normal in the animals inoculated with the three vaccine candidates. Some Rev 1 vaccinated rams showed a slight increase in body temperature and an inflammatory reaction at the inoculation site that was resolved in a few weeks. Upon challenge, no vaccinated ram developed clinical testicular lesions but these were observed in two unvaccinated rams.</p><p id="Par30">The results of the thorough bacteriological search after necropsy are summarized in Table <xref rid="Tab3" ref-type="table">3</xref> and Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>. Taken together, the results of control groups show that the experimental conditions resulted in values suitable for statistical comparisons (84.6% vs. 21.4% infected rams in the unvaccinated and Rev 1 vaccinated groups, respectively; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). The protection conferred by Bov::CA&#916;<italic toggle="yes">wadB</italic> was manifestly not significant (78.6% of infections) and that of the Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> candidate (50% of infections) not statistically different from that of the unvaccinated control group. On the other hand, H38&#916;<italic toggle="yes">wbkF</italic> conferred a level of protection (16.7% of infections) similar to that obtained with Rev 1 (Table <xref rid="Tab3" ref-type="table">3</xref>), with slightly lower percentages of infected organs and no isolation from cranial, scrotal or prefemoral lymph nodes (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>). These results were paralleled in the numbers of infected organs (Table <xref rid="Tab3" ref-type="table">3</xref>) (5.4% and 10.7% for H38&#916;<italic toggle="yes">wbkF</italic> and Rev 1, respectively) and of severely infected animals/organs (7.1%/1.8% and 7.1%/0.9% for H38&#916;<italic toggle="yes">wbkF</italic> and Rev 1, respectively).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p><bold>Protective efficacy of vaccine candidates against a </bold><bold><italic toggle="yes">B. ovis</italic></bold><bold> PA experimental challenge in rams</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Vaccine (CFU dose)</th><th align="left" colspan="1" rowspan="1">No. infected animals/total (%)<sup>a</sup></th><th align="left" colspan="1" rowspan="1">No. infected organs/total (%)<sup>b</sup></th><th align="left" colspan="1" rowspan="1">No. severely infected animals (%)<sup>a,c</sup>/no. severely infected organs (%)<sup>b</sup></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Bov::CA&#916;<italic toggle="yes">wadB</italic> (1&#8201;&#215;&#8201;10<sup>10</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">11/14 (78.6)</td><td char="(" align="char" colspan="1" rowspan="1">41/112 (36.6)</td><td char="(" align="char" colspan="1" rowspan="1">4 (28.6)<sup>d</sup>/11 (9.8)<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (2.5&#8201;&#215;&#8201;10<sup>10</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">7/14 (50.0)</td><td char="(" align="char" colspan="1" rowspan="1">30/112 (26.8)<sup>d</sup></td><td char="(" align="char" colspan="1" rowspan="1">5 (35.7)/13 (11.6)<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">H38&#916;<italic toggle="yes">wbkF</italic> (2.5&#8201;&#215;&#8201;10<sup>10</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">2/14 (16.7)<sup>e,f</sup></td><td char="(" align="char" colspan="1" rowspan="1">6/112 (5.4)<sup>e,f</sup></td><td char="(" align="char" colspan="1" rowspan="1">1 (7.1)<sup>e,f</sup>/2 (1.8)<sup>e,f</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Rev 1 (2&#8201;&#215;&#8201;10<sup>9</sup>)</td><td char="(" align="char" colspan="1" rowspan="1">3/14 (21.4)<sup>d</sup></td><td char="(" align="char" colspan="1" rowspan="1">12/112 (10.7)<sup>e</sup></td><td char="(" align="char" colspan="1" rowspan="1">1 (7.1)<sup>e</sup>/1 (0.9)<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Unvaccinated</td><td char="(" align="char" colspan="1" rowspan="1">11/13 (84.6)</td><td char="(" align="char" colspan="1" rowspan="1">64/104 (61.5)</td><td char="(" align="char" colspan="1" rowspan="1">9 (69.2)/30 (28.8)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Statistical comparisons by Chi-square test (with Fisher-Yates correction when required). <sup>b</sup>Statistical comparisons by STEPBOOT MULTTEST (SAS); <sup>c</sup>severely infected animals were those showing at least one organ sample with an infection level&#8201;&#8805;&#8201;3 (&#8805;&#8201;26&#160;CFU/plate). <sup>d</sup>Significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05) versus unvaccinated control; <sup>e</sup>High significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) vs. unvaccinated control; <sup>f</sup>no significant (<italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05) versus Rev 1 vaccinated group.</p></table-wrap-foot></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>Percentages of </bold><bold><italic toggle="yes">B. ovis</italic></bold><bold> culture positive organs in each experimental group of vaccinated rams</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13567_2022_1034_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec12"><title>Serological responses in rams</title><p id="Par31">Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref> presents the results of the antibody response to the <italic toggle="yes">B. ovis</italic> HS envelope antigens generated in vaccinated rams before and after challenge. All rams were positive in the AGID assay by week 1 after immunization, with the notable exception of those vaccinated with Bov::CA&#916;<italic toggle="yes">wadB</italic> among which very few positive responses were detected before challenge (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). In the Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and Rev 1 vaccinated groups, AGID-positive responses decreased rapidly and all animals became negative by weeks 10 and 23, respectively (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). As judged by the percentage of AGID-positive animals, H38&#916;<italic toggle="yes">wbkF</italic> elicited the most durable antibody response, with over 60% of positive animals until week 17 (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). No matter the experimental group, all rams were AGID-negative before challenge (week 33). When assessed by iELISA (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>B), the percentage of positive animals in the groups vaccinated with Bov::CA&#916;<italic toggle="yes">wadB</italic> and H38&#916;<italic toggle="yes">wbkF</italic> were higher and more persistent than those observed in the AGID test and only the group vaccinated with Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> was totally negative by the time of challenge. Interestingly, when sera from Bov::CA&#916;<italic toggle="yes">wadB</italic> vaccinated rams were studied in the iELISA with a homologous HS antigen, 100% of them were positive from week 1 until the end of the experiment (not shown). Upon challenge, most animals became both AGID and HS iELISA-positive, as expected.<fig id="Fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>Evolution of the percentages of positive rams after vaccination (week 0) and challenge (week 33) in: (A) AGID; and (B) iELISA using </bold><bold><italic toggle="yes">B. ovis</italic></bold><bold> HS extracts</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="13567_2022_1034_Fig3_HTML.jpg"/></fig></p><p id="Par32">Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref> presents the results obtained with serodiagnostic tests for S brucellae. Unsurprisingly, all animals vaccinated with Rev 1 were positive in RBT, CFT and S-LPS iELISA by week 2 and a high percentage remained positive thereafter. Although Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> bears a modified O-PS, all rams vaccinated with this candidate were positive in both RBT and CFT during the first weeks but the reactions persisted less than those induced by Rev 1. However, only very few and transient reactions were detected in the S-LPS iELISA in these Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> vaccinated rams (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>C), even though these rams showed a more intense and persistently positive response in the <italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> iELISA (Additional file <xref rid="MOESM4" ref-type="media">4</xref>). In contrast with Rev 1 and Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> vaccinates, no ram immunized with H38&#916;<italic toggle="yes">wbkF</italic> or Bov::CA&#916;<italic toggle="yes">wadB</italic> showed antibodies detectable in either RBT or CFT, and only a few of those vaccinated with H38&#916;<italic toggle="yes">wbkF</italic> showed a transiently positive and relatively early response in the S-LPS iELISA before challenge (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>). As expected, the proportion of RBT and CFT positive animals did not increase after the challenge for any of the experimental groups (Figures&#160;<xref rid="Fig4" ref-type="fig">4</xref>A and B) but 50% and less than 20%, respectively, of H38&#916;<italic toggle="yes">wbkF</italic> and Bov::CA&#916;<italic toggle="yes">wadB</italic> vaccinated rams reacted then in the S-LPS iELISA (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>C).<fig id="Fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold>Evolution of the percentages of positive rams in S-LPS tests after vaccination (week 0) and challenge (week 33): (A) RBT; (B), CFT; and (C) iELISA</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="13567_2022_1034_Fig4_HTML.jpg"/></fig></p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par33">As underlined in the Introduction, there is a need for a <italic toggle="yes">B. ovis</italic> vaccine to replace Rev 1, banned in areas where <italic toggle="yes">B. melitensis</italic> has been eradicated or has never been present. Following the evidence that live-attenuated vaccines are advantageous for triggering protective responses against <italic toggle="yes">Brucella</italic> [<xref ref-type="bibr" rid="CR47">47</xref>], in this work we investigated three vaccine candidates of this kind.</p><p id="Par34">It is known that <italic toggle="yes">Brucella</italic> behaves as a stealthy parasite that avoids detection by innate immunity at the onset of infection, thus retarding the adaptive response and facilitating to reach intracellular niches [<xref ref-type="bibr" rid="CR48">48</xref>]. This furtive behavior is related to the absence of marked pathogen-associated molecular patterns in envelope molecules, chiefly in the LPS [<xref ref-type="bibr" rid="CR48">48</xref>]. Immunological, genetic and structural investigations have established that the core of <italic toggle="yes">Brucella</italic> LPS carries a pentasaccharide branch that hinders recognition of the lipid A-inner core by the TLR4-MD2 receptor system of innate immunity [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Hence, mutations preventing the assembly of this pentasaccharide bolster Th1 immunoresponses, thereby causing attenuation [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Consequently, disruption of the core lateral branch was proposed as a strategy to develop brucellosis vaccines [<xref ref-type="bibr" rid="CR51">51</xref>] and previous work with <italic toggle="yes">B. ovis</italic> shows that the core glycosyltransferase gene <italic toggle="yes">wadB</italic> is an appropriate target for this purpose [<xref ref-type="bibr" rid="CR27">27</xref>]. Yet, we found that, when combined with CA genes of <italic toggle="yes">B. abortus</italic> to overcome the practical limitations of CO<sub>2</sub>-dependence, the <italic toggle="yes">B. ovis wadB</italic> mutant was totally ineffective as vaccine in rams even though it was protective in mice. These results mean that the mouse model failed utterly to predict a positive vaccine result in the natural host, and are in line with other data that strongly suggest that its usefulness in the search for a brucellosis live vaccine is limited to screen out overattenuated or none protective candidates [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par35">Nevertheless, the total failure of Bov::CA&#916;<italic toggle="yes">wadB</italic> as a vaccine was unexpected and, although the explanation is far from obvious, it is worthwhile to speculate on the reasons. Noteworthy, proportions of Bov::CA&#916;<italic toggle="yes">wadB</italic> vaccinated rams positive in AGID and iELISA with <italic toggle="yes">B. ovis</italic> HS were respectively lower than those in any other vaccinated group. Since all rams remained positive in the iELISA with HS of the homologous Bov::CA&#916;<italic toggle="yes">wadB</italic>, and HS is rich in R-LPS [<xref ref-type="bibr" rid="CR46">46</xref>], these results evidence the importance of the epitopes of the core branch in the antibody response to <italic toggle="yes">B. ovis</italic> LPS. In mice, a role for antibodies in <italic toggle="yes">B. ovis</italic> protective immunity has been shown in passive transfer assays with monoclonal antibodies to envelope antigens and with sera from mice immunized with RB51 (reviewed in [<xref ref-type="bibr" rid="CR35">35</xref>]). However, vaccination with HS in sheep does not show a correlation between protection and the intensity of the antibody response to these antigens [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. On the other hand, experiments with the same antigens in several adjuvant formulations provide clear evidence that a strong Th1 cell-mediated immunoresponse is important in protection in sheep [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par36">Therefore, although the lack of antibodies to the full core may play a role, we favor the hypothesis that the failure of Bov::CA&#916;<italic toggle="yes">wadB</italic> to protect against <italic toggle="yes">B. ovis</italic> was caused by an inappropriate Th1 response. This may seem paradoxical because the LPS core defect has been shown to increase recognition by LPS receptors (see above), thereby bolstering pro-inflammatory cytokine production and initiating the Th1 response at earlier times than the wild- type [<xref ref-type="bibr" rid="CR49">49</xref>]. However, this comparatively early Th1 response accelerates clearance of <italic toggle="yes">Brucella</italic> core mutants in mice [<xref ref-type="bibr" rid="CR49">49</xref>] and, as discussed below, a given permanence in the host is necessary for a vaccine to generate protective immunity. Thus, it could be that Bov::CA&#916;<italic toggle="yes">wadB</italic> clearance was too rapid to generate such a response. Investigation of these hypotheses could help to clarify the virulence mechanisms of <italic toggle="yes">B. ovis</italic> and the immunity to this comparatively less studied species, knowledge with which it may be possible to develop an homologous <italic toggle="yes">B. ovis</italic> vaccine.</p><p id="Par37">We also examined the Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construct. Based on the results in mice [<xref ref-type="bibr" rid="CR19">19</xref>], the premises were that this candidate could protect sheep against <italic toggle="yes">B. ovis</italic> and elicit antibodies that, while not interfering in standard S-LPS tests, could be useful to identify vaccinated animals. Concerning protection, we found that it was insufficient, even though in this case the differences with the results in mice were not as dramatic as those of Bov::CA&#916;<italic toggle="yes">wadB</italic>. It is worth pointing out that since the first studies with vaccine RB51 a much larger dose has been found necessary to show that some R mutants match the protection obtained with S19 or Rev 1 (reference OIE S vaccines) in mice [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], and this is also true for Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (Table <xref rid="Tab2" ref-type="table">2</xref> and [<xref ref-type="bibr" rid="CR19">19</xref>]). However, to reproduce in the natural host the 3 log dose increase applied in the mouse model is not feasible (doses over 10<sup>10</sup>&#160;CFU are not practical in sheep). Therefore, we used a dose equivalent to that of R vaccines (1&#8211;5&#8201;&#215;&#8201;10<sup>10</sup>, [<xref ref-type="bibr" rid="CR33">33</xref>]).&#160;Thus, the contrasting results&#160;obtained with Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>&#160;in rams and in mice are likely to reflect the laboratory bias in dose introduced for screening purposes and the limitations of the mouse model.</p><p id="Par38">Why Rev1::<italic toggle="yes">wbdR&#916;wbkC</italic> being smooth could require a dose larger than Rev 1 in the mouse model may reflect a defect in cell entry and/or control of intracellular trafficking caused by the O-PS modification because both are critical processes in the biology of S <italic toggle="yes">Brucella</italic> in which the wild-type O-PS plays an important role [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Concerning the specificity of the antibodies, our results show that the change in O-PS epitopic structure of Rev1::<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> is insufficient to fully abrogate the interference in standard S-LPS tests (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>) or to differentiate vaccinated and infected rams (Additional file <xref rid="MOESM4" ref-type="media">4</xref>). These results, which are reminiscent of the reactivity of IgG of infected cattle with the O-PS of the <italic toggle="yes">E. hermanii</italic> serotypes that carry N-acetyl-perosamine [<xref ref-type="bibr" rid="CR56">56</xref>] set another difference with the mouse model [<xref ref-type="bibr" rid="CR19">19</xref>] and discourage a practical use of this vaccine epitopic tagging.</p><p id="Par39">In contrast with the other candidates, H38&#916;<italic toggle="yes">wbkF</italic> generated protection in rams similar to that obtained with reference Rev 1 vaccine. In previous works, we found that an intact LPS core is necessary for an R vaccine to provide maximal protection in at least the mouse model, and <italic toggle="yes">wbkF</italic> mutants meet this requisite [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Also in keeping with the predicted function of WbkF (Table <xref rid="Tab1" ref-type="table">1</xref>), they are unable to synthesize internal O-PS precursors that would elicit anti-O-PS antibodies, an undesirable effect in an <italic toggle="yes">R</italic> vaccine that occurs in <italic toggle="yes">wadA</italic> (formerly <italic toggle="yes">wa</italic>**) and <italic toggle="yes">wzm</italic> R mutants [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Moreover, as indicated in the Introduction, this candidate was not selected only by the results in mice. In a previous work [<xref ref-type="bibr" rid="CR33">33</xref>], we found that a <italic toggle="yes">B. melitensis</italic> H38<italic toggle="yes">wbkF</italic>::Tn5 Km<sup>R</sup> mutant had an organ distribution and persistence in sheep like those of Rev 1, strongly suggesting similarly intense antigenic stimuli. All these characteristics made strain H38 and gene <italic toggle="yes">wbkF</italic> attractive for developing a <italic toggle="yes">B. ovis</italic> vaccine, and for a potential use we constructed the mutant by deletion (to avoid any potential reversibility) without antibiotic-resistance markers. Thus, although we did not evaluate again the kinetics of infection of the H38&#916;<italic toggle="yes">wbkF</italic> mutant in rams, its almost total identity with the H38<italic toggle="yes">wbkF</italic>::Tn5 Km<sup>R</sup> should result in a distribution and persistence similar to that of Rev 1 and, in fact, both elicited similarly persistent positive responses in the <italic toggle="yes">B. ovis</italic> HS-AGID.</p><p id="Par40">As predicted, vaccination with H38&#916;<italic toggle="yes">wbkF</italic> did not generate a serological interference in either RBT or CFT, tests that detect anti-O-PS antibodies [<xref ref-type="bibr" rid="CR3">3</xref>]. However, transient reactions were observed in the S-LPS ELISA, and the interference in this assay (but not in the RBT and CFT) was evident after challenge. This was not unexpected since R vaccines and <italic toggle="yes">B. ovis</italic> induce antibodies to the core epitopes shared by the R and S-LPS that, while not accessible in tests like RBT and CFT, become exposed to antibodies in ELISA and in the fluorescence polarization assay [<xref ref-type="bibr" rid="CR3">3</xref>]. Therefore, if H38&#916;<italic toggle="yes">wbkF</italic> (or any other R vaccine) is employed in <italic toggle="yes">B. melitensis-</italic>free areas where the latter two tests are used for surveillance, this cross-reactivity should be considered and the simple and inexpensive RBT implemented as a parallel test in doubtful cases. A more difficult practical problem is posed by the interference of H38&#916;<italic toggle="yes">wbkF</italic> in <italic toggle="yes">B. ovis</italic> serodiagnostic tests. Although more persistent in iELISA than in AGID, in which all animals were negative 27&#160;weeks after vaccination (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>), this is a protracted response that may hamper implementation of test and slaughter combined with H38&#916;<italic toggle="yes">wbkF</italic> vaccination for the eradication of <italic toggle="yes">B. ovis</italic> infection. More information is necessary to better assess the effects of route of vaccination, vaccine dose and the optimal age of sheep at vaccination on this diagnostic interference, as well as the efficacy of the H38&#916;<italic toggle="yes">wbkF</italic> vaccine under field conditions and the potential effects that anamnestic responses after contacts with <italic toggle="yes">B. ovis</italic> field strains may have in vaccinated animals. Given the importance of ewes in the epidemiology of <italic toggle="yes">B. ovis</italic> [<xref ref-type="bibr" rid="CR10">10</xref>], the vaccination of female sheep would be essential to a suitable control of infection. Like Rev 1, at least the <italic toggle="yes">B. melitensis</italic> B115 spontaneous <italic toggle="yes">wzm</italic> R mutant is highly abortifacient in pregnant sheep [<xref ref-type="bibr" rid="CR58">58</xref>] and this and other potential untoward effects of the H38&#916;<italic toggle="yes">wbkF</italic> vaccine in adult sheep need to be investigated. Research is in progress to further define the conditions of field use of H38&#916;<italic toggle="yes">wbkF</italic>.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec14"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2022_1034_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 1:</bold>
<bold>Primers used for mutant construction</bold>.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2022_1034_MOESM2_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 2:</bold>
<bold><italic toggle="yes">E. coli</italic></bold>
<bold>S17 &#955;pir and plasmids used for mutant construction</bold>.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2022_1034_MOESM3_ESM.tiff" position="float" orientation="portrait"><caption><p><bold>Additional file 3:</bold>
<bold>LPS characterization of vaccine candidates by SDS-PAGE electrophoresis-silver staining and Western blot analyses of SDS-proteinase K extracts.</bold> Upper panels (from [<xref ref-type="bibr" rid="CR19">19</xref>]): Analyses of (1) Rev 1, (2) Rev1::Tn7<italic toggle="yes">wbdR</italic>, and (3) Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> extracts. Lower panels: Analyses of (4) H38, (5) H38&#916;<italic toggle="yes">wbkF</italic>, (6) Bov::CA and (7) Bov::CA&#916;<italic toggle="yes">wadB</italic> extracts.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2022_1034_MOESM4_ESM.pptx" position="float" orientation="portrait"><caption><p><bold>Additional file 4:</bold>
<bold>Reactivity (%OD) in iELISA using N-formyl-perosamine wild-type S-LPS (A) or N-acetyl-perosamine S-LPS from a</bold>
<italic toggle="yes">wbdR</italic><bold>&#916;</bold><bold><italic toggle="yes">wbkC</italic></bold>
<bold>construct (B) and 46 sera from</bold>
<bold><italic toggle="yes">B. melitensis</italic></bold>
<bold>culture positive (C+) sheep, 78 brucellosis-free (BF) sheep and rams immunized with Rev1::</bold><bold><italic toggle="yes">wbdR</italic></bold><bold>&#916;</bold><bold><italic toggle="yes">wbkC</italic></bold>.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>S. Serrano, M. Uriarte and P. Hijazo for their excellent technical assistance in the laboratory, F. Jaso and I. Escota for taking care of the animals and J.L. Alabart for the statistical advice.</p></ack><notes notes-type="author-contribution"><title>Authors' contributions</title><p>PMM, RC-A, IM and JMB conceived and coordinated the study. MI supervised the genomic studies. AZ-R, BA-A, MS-B and EM-G participated in the mutant construction and characterization. NV contributed to preliminary experiments in laboratory models. MJM, SA-B, MB and PMM conducted the experiments in mice and rams. PM, JMB, RC-A and IM wrote the manuscript. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research was mainly supported by the project grant AGL2014-58795-C4-1/3/4-R (MINECO/AEI/FEDER) and partially by the Aragon Government (Grupo de Investigaci&#243;n A13_17R and A21_20R), ISTUN -Institute of Tropical Health funders (Fundaci&#243;n la CAIXA -LCF/PR/PR13/11080005- and Fundaci&#243;n Caja Navarra, Fundaci&#243;n Mar&#237;a Francisca de Roviralta, Ubesol and Inversiones Garcilaso de la Vega S.L). Part of this work also integrates into project PID2019-107601RB-C31 financed by MCIN/AEI/ 10.1303910.13039/501100011033. B. Arag&#243;n-Aranda was recipient of the PhD fellowship BES-2015-075609 (MINECO).</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par41">Procedures in mice and rams were performed in accordance with the current European (directive 86/609/EEC) and Spanish (RD 53/2013) legislations, supervised by the corresponding Ethical Committee for Animal Experimentation and authorized by the Arag&#243;n (reports No. 2014-20, 2014-21 and 2014-24) and Navarra (CEEA 045/12) Governments.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par42">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDermott</surname><given-names>J</given-names></name><name name-style="western"><surname>Grace</surname><given-names>D</given-names></name><name name-style="western"><surname>Zinsstag</surname><given-names>J</given-names></name></person-group><article-title>Economics of brucellosis impact and control in low-income countries</article-title><source>Rev Sci Tech</source><year>2013</year><volume>32</volume><fpage>249</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.20506/rst.32.1.2197</pub-id><pub-id pub-id-type="pmid">23837382</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>The one hundred year journey of the genus <italic toggle="yes">Brucella</italic> (Meyer and Shaw 1920)</article-title><source>FEMS Microbiol Rev</source><year>2020</year><volume>45</volume><fpage>fuaa045</fpage><pub-id pub-id-type="doi">10.1093/femsre/fuaa045</pub-id><pub-id pub-id-type="pmid">33016322</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ducrotoy</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>A review of the basis of the immunological diagnosis of ruminant brucellosis</article-title><source>Vet Immunol Immunopathol</source><year>2016</year><volume>171</volume><fpage>81</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2016.02.002</pub-id><pub-id pub-id-type="pmid">26964721</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>DNA polymorphism analysis of <italic toggle="yes">Brucella</italic> lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough <italic toggle="yes">Brucella</italic> species and novel species-specific markers</article-title><source>BMC Microbiol</source><year>2009</year><volume>9</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-9-92</pub-id><pub-id pub-id-type="pmid">19439075</pub-id><pub-id pub-id-type="pmcid">PMC2698832</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsolis</surname><given-names>RM</given-names></name><name name-style="western"><surname>Seshadri</surname><given-names>R</given-names></name><name name-style="western"><surname>Santos</surname><given-names>RL</given-names></name><name name-style="western"><surname>Sangari</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Lobo</surname><given-names>JM</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>MF</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Q</given-names></name><name name-style="western"><surname>Myers</surname><given-names>G</given-names></name><name name-style="western"><surname>Brinkac</surname><given-names>LM</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>WC</given-names></name><name name-style="western"><surname>Deboy</surname><given-names>RT</given-names></name><name name-style="western"><surname>Angiuoli</surname><given-names>S</given-names></name><name name-style="western"><surname>Khouri</surname><given-names>H</given-names></name><name name-style="western"><surname>Dimitrov</surname><given-names>G</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Mulligan</surname><given-names>S</given-names></name><name name-style="western"><surname>Walker</surname><given-names>RL</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PE</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>KA</given-names></name><name name-style="western"><surname>Paulsen</surname><given-names>IT</given-names></name></person-group><article-title>Genome degradation in <italic toggle="yes">Brucella ovis</italic> corresponds with narrowing of its host range and tissue tropism</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e5519</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0005519</pub-id><pub-id pub-id-type="pmid">19436743</pub-id><pub-id pub-id-type="pmcid">PMC2677664</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Picard-Hagen</surname><given-names>N</given-names></name><name name-style="western"><surname>Berthelot</surname><given-names>X</given-names></name><name name-style="western"><surname>Champion</surname><given-names>JL</given-names></name><name name-style="western"><surname>Eon</surname><given-names>L</given-names></name><name name-style="western"><surname>Lyazrhi</surname><given-names>F</given-names></name><name name-style="western"><surname>Marois</surname><given-names>M</given-names></name><name name-style="western"><surname>Peglion</surname><given-names>M</given-names></name><name name-style="western"><surname>Schuster</surname><given-names>A</given-names></name><name name-style="western"><surname>Trouche</surname><given-names>C</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Contagious epididymitis due to <italic toggle="yes">Brucella ovis</italic>: relationship between sexual function, serology and bacterial shedding in semen</article-title><source>BMC Vet Res</source><year>2015</year><volume>11</volume><fpage>125</fpage><pub-id pub-id-type="doi">10.1186/s12917-015-0440-7</pub-id><pub-id pub-id-type="pmid">26025374</pub-id><pub-id pub-id-type="pmcid">PMC4449566</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">ECDC (2019) European Centre for Disease Prevention and Control. Brucellosis. In: ECDC. Annual epidemiological report for 2017. Stockholm, Sweden. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/sites/default/files/documents/brucellosis-annual-epidemiological-report-2017.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/brucellosis-annual-epidemiological-report-2017.pdf</ext-link>.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>Retrospective and prospective perspectives on zoonotic brucellosis</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00213</pub-id><pub-id pub-id-type="pmid">24860561</pub-id><pub-id pub-id-type="pmcid">PMC4026726</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marco</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>L</given-names></name><name name-style="western"><surname>Cuervo</surname><given-names>LA</given-names></name><name name-style="western"><surname>De Heredia</surname><given-names>FB</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title><italic toggle="yes">Brucella ovis</italic> infection in two flocks of sheep</article-title><source>Vet Rec</source><year>1994</year><volume>135</volume><fpage>254</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1136/vr.135.11.254</pub-id><pub-id pub-id-type="pmid">7810048</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Lef&#232;vre</surname><given-names>PC</given-names></name><name name-style="western"><surname>Blancou</surname><given-names>JC</given-names></name><name name-style="western"><surname>Chermette</surname><given-names>R</given-names></name><name name-style="western"><surname>Uilenberg</surname><given-names>G</given-names></name></person-group><article-title><italic toggle="yes">Brucella Ovis</italic> Infection</article-title><source>Infectious and parasitic diseases of livestock</source><year>2010</year><publisher-loc>France</publisher-loc><publisher-name>Paris</publisher-name><fpage>1047</fpage><lpage>1063</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ridler</surname><given-names>AL</given-names></name><name name-style="western"><surname>West</surname><given-names>DM</given-names></name></person-group><article-title>Control of <italic toggle="yes">Brucella ovis</italic> infection in sheep</article-title><source>Vet Clin North Am Food Anim Pract</source><year>2011</year><volume>27</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2010.10.013</pub-id><pub-id pub-id-type="pmid">21215890</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Neilsen</surname><given-names>K</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>JR</given-names></name></person-group><article-title>Brucella ovis</article-title><source>Animal Brucellosis</source><year>1990</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>351</fpage><lpage>378</lpage></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Mar&#237;n CM, Mainar RC, de Miguel MJ, Andr&#233;s-Barranco S, &#193;lvarez JJ, Blasco JM, Mu&#241;oz PM (2019) Re-emergence of <italic toggle="yes">Brucella ovis</italic> infection in Arag&#243;n (Spain) after the ban of Rev 1 vaccination In: International Brucellosis Society Meeting, Chicago, EEUU. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://citarea.cita-aragon.es/citarea/bitstream/10532/4864/1/2019_420ab.pdf">https://citarea.cita-aragon.es/citarea/bitstream/10532/4864/1/2019_420ab.pdf</ext-link></mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Idrissi</surname><given-names>AH</given-names></name><name name-style="western"><surname>Benkirane</surname><given-names>A</given-names></name><name name-style="western"><surname>El Maadoudi</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouslikhane</surname><given-names>M</given-names></name><name name-style="western"><surname>Berrada</surname><given-names>J</given-names></name><name name-style="western"><surname>Zerouali</surname><given-names>A</given-names></name></person-group><article-title>Comparison of the efficacy of <italic toggle="yes">Brucella abortus</italic> strain RB51 and <italic toggle="yes">Brucella melitensis</italic> Rev 1 live vaccines against experimental infection with <italic toggle="yes">Brucella melitensis</italic> in pregnant ewes</article-title><source>Rev Sci Tech</source><year>2001</year><volume>20</volume><fpage>741</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.20506/rst.20.3.1305</pub-id><pub-id pub-id-type="pmid">11732416</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jim&#233;nez de Bag&#252;&#233;s</surname><given-names>MP</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>The <italic toggle="yes">Brucella abortus</italic> RB51 vaccine does not confer protection against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vaccine</source><year>1995</year><volume>13</volume><fpage>301</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/0264-410x(95)93317-3</pub-id><pub-id pub-id-type="pmid">7631517</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name></person-group><article-title>Characterization of <italic toggle="yes">Brucella abortus</italic> O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella ovis</italic> in the mouse model</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>3261</fpage><lpage>3271</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.6.3261-3271.2003</pub-id><pub-id pub-id-type="pmid">12761107</pub-id><pub-id pub-id-type="pmcid">PMC155776</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barberan</surname><given-names>M</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Laroucau</surname><given-names>K</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Efficacy of bp26 and bp26/omp31 <italic toggle="yes">B. melitensis</italic> Rev. 1 deletion mutants against<italic toggle="yes"> Brucella ovi</italic>s in rams</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.10.065</pub-id><pub-id pub-id-type="pmid">19007836</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zabalza-Barangua</surname><given-names>A</given-names></name><name name-style="western"><surname>San Rom&#225;n</surname><given-names>B</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name></person-group><article-title>GFP tagging of <italic toggle="yes">Brucella melitensis</italic> Rev1 allows the identification of vaccinated sheep</article-title><source>Transbound Emerg Dis</source><year>2018</year><volume>66</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1111/tbed.13053</pub-id><pub-id pub-id-type="pmid">30375177</pub-id><pub-id pub-id-type="pmcid">PMC7379934</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names>B</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mart&#237;nez-G&#243;mez</surname><given-names>E</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>Salvador-Besc&#243;s</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name></person-group><article-title>Rev 1 <italic toggle="yes">wbdR</italic> tagged vaccines against <italic toggle="yes">Brucella ovis</italic></article-title><source>Vet Res</source><year>2019</year><volume>50</volume><fpage>95</fpage><pub-id pub-id-type="doi">10.1186/s13567-019-0714-3</pub-id><pub-id pub-id-type="pmid">31730501</pub-id><pub-id pub-id-type="pmcid">PMC6858679</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Jim&#233;nez de Bag&#252;&#233;s</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Alonso-Urmeneta</surname><given-names>B</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of whole cell and subcellular vaccines against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vet Immunol Immunopathol</source><year>1993</year><volume>37</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/0165-2427(93)90198-d</pub-id><pub-id pub-id-type="pmid">8236802</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da Costa</surname><given-names>MR</given-names></name><name name-style="western"><surname>Irache</surname><given-names>JM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name></person-group><article-title>Evaluation of particulate acellular vaccines against <italic toggle="yes">Brucella ovis</italic> infection in rams</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>3038</fpage><lpage>3046</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.10.073</pub-id><pub-id pub-id-type="pmid">19887131</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#237;az</surname><given-names>AG</given-names></name><name name-style="western"><surname>Quinteros</surname><given-names>DA</given-names></name><name name-style="western"><surname>Paolicchi</surname><given-names>FA</given-names></name><name name-style="western"><surname>Rivero</surname><given-names>MA</given-names></name><name name-style="western"><surname>Palma</surname><given-names>SD</given-names></name><name name-style="western"><surname>Pardo</surname><given-names>RP</given-names></name><name name-style="western"><surname>Clausse</surname><given-names>M</given-names></name><name name-style="western"><surname>Zylberman</surname><given-names>V</given-names></name><name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name></person-group><article-title>Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vet Immunol Immunopathol</source><year>2019</year><volume>209</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2019.02.005</pub-id><pub-id pub-id-type="pmid">30885309</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Fiorentino</surname><given-names>MA</given-names></name><name name-style="western"><surname>Paolicchi</surname><given-names>FA</given-names></name><name name-style="western"><surname>Clausse</surname><given-names>M</given-names></name><name name-style="western"><surname>Manazza</surname><given-names>J</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Coria</surname><given-names>LM</given-names></name><name name-style="western"><surname>Zylberman</surname><given-names>V</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Kjeken</surname><given-names>R</given-names></name><name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name></person-group><article-title>The polymeric antigen BLSOmp31 confers protection against <italic toggle="yes">Brucella ovis</italic> infection in rams</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>6704</fpage><lpage>6711</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.08.097</pub-id><pub-id pub-id-type="pmid">19748579</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>AP</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Costa</surname><given-names>LF</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>CE</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>LN</given-names></name><name name-style="western"><surname>Farias</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>PP</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>GC</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>KW</given-names></name><name name-style="western"><surname>Maia</surname><given-names>AR</given-names></name><name name-style="western"><surname>Neves</surname><given-names>GG</given-names></name><name name-style="western"><surname>Romao</surname><given-names>EL</given-names></name><name name-style="western"><surname>Silva</surname><given-names>TM</given-names></name><name name-style="western"><surname>Mol</surname><given-names>JP</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>RM</given-names></name><name name-style="western"><surname>Araujo</surname><given-names>MS</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>EF</given-names></name><name name-style="western"><surname>Martins-Filho</surname><given-names>OA</given-names></name><name name-style="western"><surname>Brandao</surname><given-names>HM</given-names></name><name name-style="western"><surname>Paixao</surname><given-names>TA</given-names></name><name name-style="western"><surname>Santos</surname><given-names>RL</given-names></name></person-group><article-title>Encapsulated <italic toggle="yes">Brucella ovis</italic> lacking a putative ATP-binding cassette transporter (DeltaabcBA) protects against wild type <italic toggle="yes">Brucella ovis</italic> in Rams</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0136865</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0136865</pub-id><pub-id pub-id-type="pmid">26317399</pub-id><pub-id pub-id-type="pmcid">PMC4552948</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>AP</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Silva</surname><given-names>TM</given-names></name><name name-style="western"><surname>Ximenes</surname><given-names>LC</given-names></name><name name-style="western"><surname>Brandao</surname><given-names>HM</given-names></name><name name-style="western"><surname>Paixao</surname><given-names>TA</given-names></name><name name-style="western"><surname>Santos</surname><given-names>RL</given-names></name></person-group><article-title>Protection of an encapsulated live attenuated strain of <italic toggle="yes">Brucella ovis</italic> (DeltaabcBA) against experimental challenge in the murine model</article-title><source>Clin Vaccine Immunol</source><year>2015</year><volume>22</volume><fpage>789</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1128/cvi.00191-15</pub-id><pub-id pub-id-type="pmid">25947146</pub-id><pub-id pub-id-type="pmcid">PMC4478529</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Experimental <italic toggle="yes">Brucella ovis</italic> infection in pregnant ewes</article-title><source>Vet Rec</source><year>1999</year><volume>144</volume><fpage>555</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1136/vr.144.20.555</pub-id><pub-id pub-id-type="pmid">10371013</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soler-LLorens</surname><given-names>P</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zabalza-Barangua</surname><given-names>A</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Conde</surname><given-names>R</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>San Rom&#225;n</surname><given-names>B</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M-J</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name></person-group><article-title>Mutants in the lipopolysaccharide of <italic toggle="yes">Brucella ovis</italic> are attenuated and protect against <italic toggle="yes">B. ovis</italic> infection in mice</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s13567-014-0072-0</pub-id><pub-id pub-id-type="pmid">25029920</pub-id><pub-id pub-id-type="pmcid">PMC4107470</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sancho</surname><given-names>P</given-names></name><name name-style="western"><surname>Tejedor</surname><given-names>C</given-names></name><name name-style="western"><surname>Sidhu-Mu&#241;oz</surname><given-names>RS</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Lago</surname><given-names>L</given-names></name><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name></person-group><article-title>Evaluation in mice of <italic toggle="yes">Brucella</italic><italic toggle="yes">ovis</italic> attenuated mutants for use as live vaccines against <italic toggle="yes">B.</italic><italic toggle="yes">ovis</italic> infection</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-45-61</pub-id><pub-id pub-id-type="pmid">24898325</pub-id><pub-id pub-id-type="pmcid">PMC4057616</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sidhu-Mu&#241;oz</surname><given-names>RS</given-names></name><name name-style="western"><surname>Sancho</surname><given-names>P</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Tejedor</surname><given-names>C</given-names></name><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name></person-group><article-title>Characterization of cell envelope multiple mutants of <italic toggle="yes">Brucella ovis</italic> and assessment in mice of their vaccine potential</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>2230</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02230</pub-id><pub-id pub-id-type="pmid">30294312</pub-id><pub-id pub-id-type="pmcid">PMC6158377</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name><name name-style="western"><surname>P&#233;rez-Etayo</surname><given-names>L</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name></person-group><article-title>Disruption of pyruvate phosphate dikinase in <italic toggle="yes">Brucella ovis</italic> PA CO<sub>2</sub>-dependent and independent strains generates attenuation in the mouse model</article-title><source>Vet Res</source><year>2020</year><volume>51</volume><fpage>101</fpage><pub-id pub-id-type="doi">10.1186/s13567-020-00824-7</pub-id><pub-id pub-id-type="pmid">32795361</pub-id><pub-id pub-id-type="pmcid">PMC7427901</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Etayo</surname><given-names>L</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Khames</surname><given-names>M</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name></person-group><article-title>The CO<sub>2</sub>-dependence of <italic toggle="yes">Brucella ovis</italic> and <italic toggle="yes">Brucella abortus</italic> biovars is caused by defective carbonic anhydrases</article-title><source>Vet Res</source><year>2018</year><volume>49</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s13567-018-0583-1</pub-id><pub-id pub-id-type="pmid">30185220</pub-id><pub-id pub-id-type="pmcid">PMC6126018</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>RM</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>A</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Brucellosis vaccines: assessment of <italic toggle="yes">Brucella melitensis</italic> lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e2760</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002760</pub-id><pub-id pub-id-type="pmid">18648644</pub-id><pub-id pub-id-type="pmcid">PMC2453230</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrio</surname><given-names>MB</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name></person-group><article-title>Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against <italic toggle="yes">Brucella melitensis</italic> infection of sheep</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>1741</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.025</pub-id><pub-id pub-id-type="pmid">19186196</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">OIE (2018) Brucellosis (<italic toggle="yes">Brucella abortus, B. melitensis</italic> and <italic toggle="yes">B. suis</italic>) (infection with <italic toggle="yes">B. abortus, B. melitensis</italic> and <italic toggle="yes">B. suis</italic>). NB: Version adopted in May 2016. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2018 Off Int Epizoot, Par&#237;s, pp 1&#8211;44. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/3.01.04_BRUCELLOSIS.pdf">https://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/3.01.04_BRUCELLOSIS.pdf</ext-link></mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Estevan</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barberan</surname><given-names>M</given-names></name><name name-style="western"><surname>Irache</surname><given-names>JM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> outer membrane complex-loaded microparticles as a vaccine against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>1897</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.10.042</pub-id><pub-id pub-id-type="pmid">16337315</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Palacios-Chaves</surname><given-names>L</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Hanniffy</surname><given-names>S</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name></person-group><article-title>The identification of <italic toggle="yes">wadB</italic>, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of <italic toggle="yes">Brucella abortus</italic></article-title><source>Microb Pathog</source><year>2014</year><volume>73</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2014.06.002</pub-id><pub-id pub-id-type="pmid">24927935</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>R</given-names></name><name name-style="western"><surname>Priefer</surname><given-names>U</given-names></name><name name-style="western"><surname>P&#252;hler</surname><given-names>A</given-names></name></person-group><article-title>A broad host range mobilization system for <italic toggle="yes">in vivo</italic> genetic engineering: transposon mutagenesis in Gram negative bacteria</article-title><source>Nat Biotechnol</source><year>1983</year><volume>1</volume><fpage>784</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1038/nbt1183-784</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names>B</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>L&#225;zaro-Ant&#243;n</surname><given-names>L</given-names></name><name name-style="western"><surname>Salvador-Besc&#243;s</surname><given-names>M</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name></person-group><article-title>Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic <italic toggle="yes">B.</italic><italic toggle="yes">suis</italic> biovar 2 background</article-title><source>Vet Res</source><year>2020</year><volume>51</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/s13567-020-00815-8</pub-id><pub-id pub-id-type="pmid">32703299</pub-id><pub-id pub-id-type="pmcid">PMC7376850</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez-G&#243;mez</surname><given-names>E</given-names></name><name name-style="western"><surname>Stahle</surname><given-names>J</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>Zaccheus</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name></person-group><article-title>Genomic insertion of a heterologous acetyltransferase generates a new lipopolysaccharide antigenic structure in <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella melitensis</italic></article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1092</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01092</pub-id><pub-id pub-id-type="pmid">29887851</pub-id><pub-id pub-id-type="pmcid">PMC5981137</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Alton GG, Jones LM, Angus RD, Verger JM (1988) Techniques for the brucellosis laboratory. Institut National de la Reserche Agronomique, Paris, France. ISBN 2738000428</mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Manterola</surname><given-names>L</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name></person-group><article-title>Increases of efficacy as vaccine against <italic toggle="yes">Brucella abortus</italic> infection in mice by simultaneous inoculation with avirulent smooth <italic toggle="yes">bvrS/bvrR</italic> and rough <italic toggle="yes">wbkA</italic> mutants</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>2910</fpage><lpage>2916</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.12.038</pub-id><pub-id pub-id-type="pmid">16439039</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Dieste</surname><given-names>L</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Development of a selective culture medium for primary isolation of the main <italic toggle="yes">Brucella</italic> Species</article-title><source>J Clin Microbiol</source><year>2011</year><volume>49</volume><fpage>1458</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1128/jcm.02301-10</pub-id><pub-id pub-id-type="pmid">21270216</pub-id><pub-id pub-id-type="pmcid">PMC3122841</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Garc&#237;a-Yoldi</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>AC</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>R</given-names></name><name name-style="western"><surname>de Sa</surname><given-names>MIC</given-names></name><name name-style="western"><surname>Walravens</surname><given-names>K</given-names></name><name name-style="western"><surname>Albert</surname><given-names>D</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all <italic toggle="yes">Brucella</italic> species, including the vaccine strains</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>3484</fpage><lpage>3487</lpage><pub-id pub-id-type="doi">10.1128/jcm.00837-08</pub-id><pub-id pub-id-type="pmid">18716225</pub-id><pub-id pub-id-type="pmcid">PMC2566117</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Boadella</surname><given-names>M</given-names></name><name name-style="western"><surname>Arnal</surname><given-names>M</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Revilla</surname><given-names>M</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>D</given-names></name><name name-style="western"><surname>Vicente</surname><given-names>J</given-names></name><name name-style="western"><surname>Acevedo</surname><given-names>P</given-names></name><name name-style="western"><surname>Oleaga</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruiz-Fons</surname><given-names>F</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Prieto</surname><given-names>JM</given-names></name><name name-style="western"><surname>de la Fuente</surname><given-names>J</given-names></name><name name-style="western"><surname>Barral</surname><given-names>M</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>de Luco</surname><given-names>DF</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gortazar</surname><given-names>C</given-names></name></person-group><article-title>Spatial distribution and risk factors of Brucellosis in Iberian wild ungulates</article-title><source>BMC Infect Dis</source><year>2010</year><volume>10</volume><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-10-46</pub-id><pub-id pub-id-type="pmid">20205703</pub-id><pub-id pub-id-type="pmcid">PMC2841660</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">OIE (2018) Ovine epidydimitis (<italic toggle="yes">Brucella ovis</italic>). Chapter 3.7.7. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Version adopted by the world assembly of OIE delegates in May 2018). Paris, France. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/3.07.07_OVINE_EPID.pdf">https://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/3.07.07_OVINE_EPID.pdf</ext-link></mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riezu-Boj</surname><given-names>JI</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name></person-group><article-title>Antibody response to <italic toggle="yes">Brucella ovis</italic> outer membrane proteins in ovine brucellosis</article-title><source>Infect Immun</source><year>1990</year><volume>58</volume><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1128/iai.58.2.489-494.1990</pub-id><pub-id pub-id-type="pmid">2298488</pub-id><pub-id pub-id-type="pmcid">PMC258483</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>A</given-names></name><name name-style="western"><surname>Cabello</surname><given-names>A</given-names></name><name name-style="western"><surname>Akoolo</surname><given-names>L</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>A</given-names></name><name name-style="western"><surname>Arenas-Gamboa</surname><given-names>A</given-names></name><name name-style="western"><surname>McMurray</surname><given-names>D</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><name name-style="western"><surname>de Figueiredo</surname><given-names>P</given-names></name></person-group><article-title>The case for live attenuated vaccines against the neglected zoonotic diseases Brucellosis and Bovine Tuberculosis</article-title><source>PLoS Negl Trop Dis</source><year>2016</year><volume>10</volume><fpage>e0004572</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0004572</pub-id><pub-id pub-id-type="pmid">27537413</pub-id><pub-id pub-id-type="pmcid">PMC4990199</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name><name name-style="western"><surname>Guzm&#225;n-Verri</surname><given-names>C</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>Rucavado</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><fpage>e631</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0000631</pub-id><pub-id pub-id-type="pmid">17637846</pub-id><pub-id pub-id-type="pmcid">PMC1910614</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mancek-Keber</surname><given-names>M</given-names></name><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Palacios-Chaves</surname><given-names>L</given-names></name><name name-style="western"><surname>Chacon-Diaz</surname><given-names>C</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Martirosyan</surname><given-names>A</given-names></name><name name-style="western"><surname>von Bargen</surname><given-names>K</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Jerala</surname><given-names>R</given-names></name><name name-style="western"><surname>Brandenburg</surname><given-names>K</given-names></name><name name-style="western"><surname>Llobet</surname><given-names>E</given-names></name><name name-style="western"><surname>Bengoechea</surname><given-names>JA</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>The lipopolysaccharide core of <italic toggle="yes">Brucella abortus</italic> acts as a shield against innate immunity recognition</article-title><source>PLoS pathog</source><year>2012</year><volume>8</volume><fpage>e1002675</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002675</pub-id><pub-id pub-id-type="pmid">22589715</pub-id><pub-id pub-id-type="pmcid">PMC3349745</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontana</surname><given-names>C</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Stahle</surname><given-names>J</given-names></name><name name-style="western"><surname>Holst</surname><given-names>O</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Hanniffy</surname><given-names>S</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name></person-group><article-title>Structural studies of lipopolysaccharide defective mutants from <italic toggle="yes">Brucella melitensis</italic> identify a core oligosaccharide critical in virulence</article-title><source>J Biol Chem</source><year>2016</year><volume>291</volume><fpage>7727</fpage><lpage>7741</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.701540</pub-id><pub-id pub-id-type="pmid">26867577</pub-id><pub-id pub-id-type="pmcid">PMC4817197</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Lipopolysaccharide as a target for brucellosis vaccine design</article-title><source>Microb Pathog</source><year>2013</year><volume>58</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2012.11.011</pub-id><pub-id pub-id-type="pmid">23219811</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Mainar-Jaime</surname><given-names>RC</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status</article-title><source>Vet Res</source><year>2004</year><volume>35</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1051/vetres:2003037</pub-id><pub-id pub-id-type="pmid">15099501</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>What have we learned from brucellosis in the mouse model?</article-title><source>Vet Res</source><year>2012</year><volume>43</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-43-29</pub-id><pub-id pub-id-type="pmid">22500859</pub-id><pub-id pub-id-type="pmcid">PMC3410789</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martirosyan</surname><given-names>A</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>An evolutionary strategy for a stealthy intracellular <italic toggle="yes">Brucella</italic> pathogen</article-title><source>Immunol Rev</source><year>2011</year><volume>240</volume><fpage>211</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00982.x</pub-id><pub-id pub-id-type="pmid">21349096</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porte</surname><given-names>F</given-names></name><name name-style="western"><surname>Naroeni</surname><given-names>A</given-names></name><name name-style="western"><surname>Ouahrani-Bettache</surname><given-names>S</given-names></name><name name-style="western"><surname>Liautard</surname><given-names>JP</given-names></name></person-group><article-title>Role of the <italic toggle="yes">Brucella suis</italic> lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>1481</fpage><lpage>1490</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.3.1481-1490.2003</pub-id><pub-id pub-id-type="pmid">12595466</pub-id><pub-id pub-id-type="pmcid">PMC148865</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>D</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>R</given-names></name><name name-style="western"><surname>Mainar-Jaime</surname><given-names>RC</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to <italic toggle="yes">Yersinia enterocolitica</italic> O:9</article-title><source>Clin Diagn Lab Immunol</source><year>2005</year><volume>12</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1128/CDLI.12.1.141-151.2005</pub-id><pub-id pub-id-type="pmid">15642999</pub-id><pub-id pub-id-type="pmcid">PMC540215</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinley Morgan</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Littlejohn</surname><given-names>AI</given-names></name><name name-style="western"><surname>MacKinnon</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>JR</given-names></name></person-group><article-title>The degree of protection given by living vaccines against experimental infection with <italic toggle="yes">Brucella melitensis</italic> in goats</article-title><source>Bull World Health Org</source><year>1966</year><volume>34</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">5295563</pub-id><pub-id pub-id-type="pmcid">PMC2475954</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Sancho</surname><given-names>M</given-names></name><name name-style="western"><surname>Adone</surname><given-names>R</given-names></name><name name-style="western"><surname>Garc&#237;a-Seco</surname><given-names>T</given-names></name><name name-style="western"><surname>Tarantino</surname><given-names>M</given-names></name><name name-style="western"><surname>Diez-Guerrier</surname><given-names>A</given-names></name><name name-style="western"><surname>Drumo</surname><given-names>R</given-names></name><name name-style="western"><surname>Francia</surname><given-names>M</given-names></name><name name-style="western"><surname>Dom&#237;nguez</surname><given-names>L</given-names></name><name name-style="western"><surname>Pasquali</surname><given-names>P</given-names></name><name name-style="western"><surname>&#193;lvarez</surname><given-names>J</given-names></name></person-group><article-title>Evaluation of the immunogenicity and safety of <italic toggle="yes">Brucella melitensis</italic> B115 vaccination in pregnant sheep</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>1877</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.01.070</pub-id><pub-id pub-id-type="pmid">24508034</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>